do Carmo Jussara M, Tallam Lakshmi S, Roberts John V, Brandon Elizabeth L, Biglane John, da Silva Alexandre A, Hall John E
Dept. of Physiology and Biophysics, Univ. of Mississippi Medical Center, 2500 North State St., Jackson, MS 39216-4505, USA.
Am J Physiol Regul Integr Comp Physiol. 2009 Sep;297(3):R803-12. doi: 10.1152/ajpregu.00187.2009. Epub 2009 Jul 15.
The purpose of this study was to determine the long-term impact of obesity and related metabolic abnormalities in the absence and presence of hypertension on renal injury and salt-sensitivity of blood pressure. Markers of renal injury and blood pressure salt sensitivity were assessed in 52- to 55-wk-old normotensive melanocortin-4 receptor-deficient (MC4R-/-) mice and lean C57BL/6J wild-type (WT) mice and in 22-wk-old MC4R-/- and WT mice made hypertensive by N(G)-nitro-L-arginine methyl ester (L-NAME) in the drinking water for 8 wk. Old MC4R-/- mice were 60% heavier, hyperinsulinemic, and hyperleptinemic but had similar mean arterial pressure (MAP) as WT mice (115 +/- 2 and 117 +/- 2 mmHg) on normal salt diet (0.4% NaCl). A high-salt diet (4.0% NaCl) for 12 days did not raise MAP in obese or lean mice [DeltaMAP: MC4R (-/-) 4 +/- 2 mmHg; WT, 2 +/- 1 mmHg]. Obese MC4R-/- mice had 23% greater glomerular tuft area and moderately increased GFR compared with WT mice. Bowman's space, total glomerular area, mesangial matrix, urinary albumin excretion (UAE), renal TGF-beta and collagen expression were not significantly different between old MC4R-/- and WT mice. Renal lipid content was greater but renal macrophage count was markedly lower in MC4R-/- than WT mice. Mild increases in MAP during L-NAME treatment (approximately 16 mmHg) caused small, but greater, elevations in UAE, renal TGF-beta content, and macrophage infiltration in MC4R-/- compared with WT mice without significant changes in glomerular structure. Thus despite long-term obesity and multiple metabolic abnormalities, MC4R-/- mice have no evidence of renal injury or salt-sensitivity of blood pressure. These observations suggest that elevations in blood pressure may be necessary for obesity and related metabolic abnormalities to cause major renal injury or that MC4R-/- mice are protected from renal injury by mechanisms that are still unclear.
本研究的目的是确定在无高血压和有高血压情况下,肥胖及相关代谢异常对肾损伤和血压盐敏感性的长期影响。在52至55周龄的正常血压黑素皮质素-4受体缺陷(MC4R-/-)小鼠和瘦型C57BL/6J野生型(WT)小鼠中,以及在22周龄通过饮用含N(G)-硝基-L-精氨酸甲酯(L-NAME)的水8周而患高血压的MC4R-/-和WT小鼠中,评估肾损伤标志物和血压盐敏感性。老年MC4R-/-小鼠体重重60%,存在高胰岛素血症和高瘦素血症,但在正常盐饮食(0.4%NaCl)下,其平均动脉压(MAP)与WT小鼠相似(分别为115±2和117±2 mmHg)。给予高盐饮食(4.0%NaCl)12天,未使肥胖或瘦型小鼠的MAP升高[MAP变化:MC4R(-/-)为4±2 mmHg;WT为2±1 mmHg]。与WT小鼠相比,肥胖的MC4R-/-小鼠肾小球毛细血管丛面积大23%,肾小球滤过率(GFR)适度增加。老年MC4R-/-和WT小鼠之间,鲍曼间隙、肾小球总面积、系膜基质、尿白蛋白排泄(UAE)、肾转化生长因子-β(TGF-β)和胶原蛋白表达无显著差异。MC4R-/-小鼠的肾脂质含量更高,但肾巨噬细胞计数明显低于WT小鼠。与WT小鼠相比,L-NAME治疗期间MAP轻度升高(约16 mmHg)使MC4R-/-小鼠的UAE、肾TGF-β含量和巨噬细胞浸润有小幅但更大幅度的升高,而肾小球结构无显著变化。因此,尽管存在长期肥胖和多种代谢异常,但MC4R-/-小鼠没有肾损伤或血压盐敏感性的证据。这些观察结果表明,血压升高可能是肥胖及相关代谢异常导致严重肾损伤的必要条件,或者MC4R-/-小鼠通过尚不清楚的机制免受肾损伤。